Next-Generation Sequencing (NGS) Market

Product Launches, Product Enhancements, and Service Launches are the Key Growth Strategies Adopted by Players in the Global Next-Generation Sequencing Market

The global next-generation sequencing market is projected to reach USD 16.35 billion by 2024 from USD 5.70 billion in 2018, at a CAGR of 19.2%. Factors such as advancements in NGS platforms, declining NGS capital cost coupled with the decreasing cost of sequencing, and improving regulatory & reimbursement scenario for NGS-based diagnostic tests are expected to propel the growth of next-generation sequencing market.

Some of the prominent players in the next-generation sequencing market are Illumina, Inc. (US), Thermo Fisher Scientific, Inc. (US), Pacific Biosciences of California, Inc. (US), BGI (China), PerkinElmer (US), Agilent Technologies (US), QIAGEN N. V. (Germany), Macrogen Inc. (South Korea), Oxford Nanopore Technologies, Ltd. (UK), and Eurofins Scientific (Luxembourg).

Analysis of the developments in the next-generation sequencing market from 2015 to 2018 shows that product launches, product enhancements, and service launches are the most widely adopted growth strategy by players in the market. Players adopted this strategy to strengthen their market positions.

To know about the assumptions considered for the study download the pdf brochure

In 2017, Illumina (US) held the leadership position in the next-generation sequencing market. The company has flagship NGS platforms, such as the iSeq 100 system, NovaSeq 6000, HiSeq Series, MiSeq Series, NextSeq 500, and HiSeq X Ten & HiSeq X Five. The company also provides reagents such as TruSeq sample preparation kits, TruSeq SBS sequencing kits, and other sequencing reagents. It also provides sequencing services such as whole-genome sequencing, human whole-exome sequencing, de novo sequencing, custom-targeted resequencing, gene expression using random-primed RNA sampling, and other related services. The company focuses on further strengthening its position in the market by entering into numerous agreements and partnerships with other small players and launching new products to strengthen its product portfolio in the market. From 2015 to 2018 (July), the company launched more than 15 products and entered into 17 agreements, partnerships, and collaborations.

Thermo Fisher Scientific held the second position in the NGS market. The company’s leading position in the market can be attributed to its strong global presence and well-established supply chain. Thermo Fisher focuses on delivering innovative tools by developing new products to enable healthcare professionals to rationally design, assemble, and order synthetic genetic parts. In the last few years, the company launched a number of products, including the Ion AmpliSeq HD technology, Oncomine Childhood Cancer Research Assay NGS panel, Ion GeneStudio S5 Series NGS instruments, Precision ID GlobalFiler NGS STR Panel v2, and Converge Software 2.

Related Reports:

Next-Generation Sequencing (NGS) Market by Product (NovaSeq, NextSeq, Sequel, Nanopore), Consumables, Bioinformatics, Services (Exome, RNA, DeNovo), Technology (Ion, SMRT), Application (Diagnostics, Cancer), End User (Academia) - Global Forecasts to 2024

Contact:
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com

Report Code
BT 2697
Published ON
Aug, 2018
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Next-Generation Sequencing (NGS) Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
REQUEST A FREE WORKSHOP
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
ONLINE CHAT
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
© MarketsandMarkets Research Private Ltd. All rights reserved